One-Time CAR-T Leader Juno Shows Off Promising New Clinical Data Post author:Sam Post published:November 1, 2017 Post category:BioPharma The company submitted 15 abstracts to be presented at the upcoming ASH Conference. Source: BioSpace You Might Also Like What Happens to the FDA if the Government Shuts Down January 17, 2018 Why the Best is Yet to Come for This Tiny Massachusetts Biotech November 27, 2017 ORIC Pharmaceuticals Snags $50 Million to Advance Lead Asset for Treatment-Resistant Cancers February 20, 2018
ORIC Pharmaceuticals Snags $50 Million to Advance Lead Asset for Treatment-Resistant Cancers February 20, 2018
